Doximity Reports Q1 Revenue Miss, Announces Strategic AI Partnership
DOCS is trading near its 52-week low of $20.55 (6.8% below the low) on elevated volume (3.9× avg).
Summary
Doximity reported Q1 adjusted EPS of $0.46, slightly above estimates, but revenue of $145.37 million missed analyst expectations. This follows yesterday's reports of the company's Q4 FY26 financial results, which included a significant decline in profit to $19.1 million (matching the net income figure in this report), and Q1 revenue guidance of $151-$152 million. The reported Q1 revenue is below this guidance. The company also announced a new partnership with Aledade to integrate Doximity's Clinical AI Suite, a positive development for expanding its AI tools and user engagement. While the CFO change was previously disclosed, the specific Q1 revenue miss is a new negative financial detail, partially offset by the EPS beat and the strategic partnership.
At the time of this announcement, DOCS was trading at $19.15 on NYSE in the Technology sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $20.55 to $76.51. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.